Abstract:Neurodegenerative diseases, such as Alzheimer's disease, Parkinson's disease, Huntington's disease, amyotrophic lateral sclerosis, and others, are characterized by progressive loss of neuronal cells, which causes memory impairment and cognitive decline. Mounting evidence demonstrated the possible implications of diverse biological processes, namely oxidative stress, mitochondrial dysfunction, aberrant cell cycle re-entry, post-translational modifications, protein aggregation, impaired proteasome dysfunction, autophagy, and many others that cause neuronal cell death. The condition worsens as there is no effective treatment for such diseases due to their complex pathogenesis and mechanism. Mounting evidence demonstrated the role of regulatory transcription factors, such as NFκβ, FoxO, Myc, CREB, and others that regulate the biological processes and diminish the disease progression and pathogenesis. Studies demonstrated that forkhead box O (FoxO) transcription factors had been implicated in the regulation of aging and longevity. Further, the functions of FoxO proteins are regulated by different post-translational modifications (PTMs), namely acetylation, and ubiquitination. Various studies concluded that FoxO proteins exert both neuroprotective and neurotoxic properties depending on their regulation mechanism and activity in the brain. Thus, understanding the nature of FoxO expression and activity in the brain will help develop effective therapeutic strategies. Herein, firstly, we discuss the role of FoxO protein in cell cycle regulation and cell proliferation, followed by the regulation of FoxO proteins through acetylation and ubiquitination. We also briefly explain the activity and expression pattern of FoxO proteins in the neuronal cells and explain the mechanism through which FoxO proteins are rescued from oxidative stress-induced neurotoxicity. Later on, we present a detailed view of the implication of FoxO proteins in neurodegenerative disease and FoxO proteins as an effective therapeutic target.

Regulation of mitochondrial function by FOXOs in ischemic stroke and Alzheimer’s disease

FOXO and related transcription factors binding elements in the regulation of neurodegenerative disorders

Role of Forkhead Box Protein O1 (FoxO1) in Stroke: A Literature Review

FOXO Transcription Factors: Their Clinical Significance and Regulation.

Mitochondria and Forkhead Box Protein O 3A

The forkhead box O3 (FOXO3): a key player in the regulation of ischemia and reperfusion injury

FoxO transcription factors in mitochondrial homeostasis

Therapeutic strategies targeting FOXO transcription factors

FOXOs in the Impaired Heart: New Therapeutic Targets for Cardiac Diseases.

The rules and regulatory mechanisms of FOXO3 on inflammation, metabolism, cell death and aging in hosts

Regulation of Forkhead Transcription Factor Foxo3a Contributes to Calorie Restriction-Induced Prevention of Alzheimer'S Disease-Type Amyloid Neuropathology and Spatial Memory Deterioration

Hdac2 Selectively Regulates Foxo3a-Mediated Gene Transcription During Oxidative Stress-Induced Neuronal Cell Death

Tissue-Specific Metabolic Regulation of FOXO-Binding Protein: FOXO Does Not Act Alone

mTORC2 Is the Major Second Layer Kinase Negatively Regulating FOXO3 Activity

FoxO Proteins in the Nervous System

New Insights for FOXO and Cell-Fate Decision in HIV Infection and HIV Associated Neurocognitive Disorder

FOXO1 inhibition potentiates endothelial angiogenic functions in diabetes via suppression of mitochondrial fission

The role of Foxo3a in neuron-mediated cognitive impairment

Energy Stress Modulation of AMPK/FoxO3 Signaling Inhibits Mitochondria-Associated Ferroptosis

Metabolic aspects of cardiovascular diseases: Is FoxO1 a player or a target?

Advances in the Researches of the Biological Function of Transcription Factors FOXOs